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Abstract 
Background: Black Seed (BS) is used in traditional medicine as a therapy for a variety of diseases including allergic 
asthma.  
Materials and Methods: In the present study, anti-inflammatory and immunomodulatory effects of BS on cytokine 
gene expression, lung airway eosinophilia and goblet cell hyperplasia were examined in a mouse mice model of 
allergic asthma. Groups of 6-week-old female BALB/c mice were sensitized by intraperitoneal injections of OVA 
plus alum on days 1 and 14. On days 24, 26, 28 and 30, the mice were exposed to OVA in saline for 30 min with 
nebulizer. Similar experiments were conducted with mice receiving saline as a negative control. 
Results: The mouse allergic asthma model received BS by food on days 23, 25, 27 and 29. Then, the percentage of 
inflammatory cells as well as mRNA expression levels of interleukin (IL)-4, IL-5, IL-13 and mucin (MUC5a) genes 
were survived in Broncho-alveolar lavage fluid (BALF). Furthermore, we attempted to examine histopathological 
examination of the lung. Mice receiving BS showed a significant decrease in the number of eosinophils, and a 
potential inhibitory effect on mRNA expression levels of Th2-driven immune response cytokines and mucin, 
resulting in decreased production of interleukin and mucin in allergic asthma. 
Conclusion: Our findings suggested that BS has an anti-inflammatory and immunomodulatory effect during the 
allergic response in the lung, and can be a promising treatment for allergic asthma in humans. 
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Allergic Asthma is a multifactorial disease of 
airways characterized by airway spasm, lung 
eosinophilia, mucus hypersecretion resulting from 
goblet cells, elevated serum IgE levels and increased 
airway responsiveness to allergens. Approximately 
300 million people from  all ages suffer from asthma 
worldwide (1-6). Th2 cytokines, such as IL-4, IL-5 
and IL-13, are believed to play an important role in 
asthma development and progression. These cytokines 
are involved in overproduction of IgE, activated and 
increased eosinophils in the airways as well as 
development of airway hyper responsiveness (AHR) to 
allergens (7). 
Nigella sativa, an annual flowering plant in the 
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family Ranunculaceae, is one of the most widely 
used traditional medicine generally known as black 
seed (BS) or black cumin (8, 9).Since ancient times, 
it has been used as a food additive, preservative and 
herbal remedy for various diseases. A lot of studies 
have shown that BS is an excellent cure capable to 
prevent a variety of diseases, including those related 
to the gastrointestinal, immune and nervous systems, 
as well as respiratory disorders such as asthma (8, 10, 
11). Black seed oil (BSO) is commonly used in 
traditional medicine because of the presence of 
highly-active constituents such as conjugated linoleic 
acid, thymoquinone, nigellone (dithymoquinone), 
thymol, thymohydroquinone, melanthin, nigilline and 
trans-anethole (11-13). These constituents allow BS 
to prevent and control infections, allergies and 
chronic diseases. Recent studies on the 
pharmacological effects of BS have demonstrated its 
anti-inflammatory and immunomodulatory properties 
(6, 8). In addition, several studies showed that BS has 
the inhibitory effect on cytokine production and 
activation (12-15). 
The aims of this study were to investigate the 
immunomodulatory and anti-inflammatory effects of 
BS on ovalbumin (OVA)-induced allergic asthma in 
mice. The extent of antigen induced inflammatory 
infiltration in the bronchial airways and 
histopathological changes in lung tissues was 
investigated. In addition, we evaluated the effect of 
BS on the expression level of IL-4, IL-5, IL-13 and 
MUC5a genes in OVA-induced asthmatic mice. 
Methods 
Animals 
Forty-two 6-week-old female BALB/c mice 
were purchased from Pasteur institute of Iran 
(Tehran, Iran). The mice were kept in an allergen-
free environment in plastic cages, and received food 
and water ad libitum at 18-24°C temperature with a 
relative humidity of 30-60% and a 12-hour light/dark 
cycle. Water, food, drinking containers and storage 
cage supplies were sterilized and changed daily. 
Antigen Sensitization, challenge and treatment 
The mice were immunized with two methods, 
intraperitoneal injection and inhalation aerosol of 
Ovalbumin (OVA). The mice were divided into three 
groups of the same gender, race and age as follows: 
Group1 was actively sensitized by intraperitoneal 
injections of 20 μg OVA (Sigma Aldrich, USA) with 1 
mg of alum on days 1 and 14. Then, the mice were 
inhaled with 1 % OVA solution (in sterile 
physiological saline) aerosolized by ultrasonic 
nebulizer (NE-U07, Omrom, Japan) on days 24, 26, 
28, and 30 for 30 min per day (Positive control); 
Group 2 includes allergic asthma models (similar to 
group 1) receiving BS by food on days 23, 25, 27 and 
29; and group 3 contains healthy mice receiving 
normal saline (as a negative control). After day 31, 
exams were done and the groups were compared using 
statistical methods. 
RNA extraction from broncho-alveolar lavage fluid 
(BALF) 
BAL fluid was collected from animals, 
centrifuged in sterile centrifuge tubes for 5 minutes at 
500 × rpm at 4°C, and then washed twice with PBS. 
Afterwards, the cell pellet was suspended in PBS. 
Total RNA was extracted from BAL fluid using the 
TRIzol reagent according to the manufacturer’s 
specifications. RNA concentration was quantified by 
measuring optical density (OD) at 260 nm (Eppendorf, 
Homburg, Germany). The extracted RNA was stored 
at -70°C until cDNA synthesis. 
Construction of cDNA from total RNA of BALF 
Total RNA samples were converted to single-
stranded cDNA by using the Maxima First Strand 
cDNA Synthesis Kit, according to the manufacturer's 
instruction (RevertAid, Fermentas Life Sciences, 
International INC, Canada). The product of the first 
strand cDNA synthesis was used directly in qPCR or 
stored at -20°C for up to one week and -70°C for 
longer storage. 
Real-Time quantitative PCR 
In the present study, real-time PCR was carried 
out using SYBR Green I as a fluorescent dyes. The 
primer design was based on the target gene nucleotide 
sequences from the NCBI Nucleotide database (Gene 
Bank, access: http://www.ncbi.nlm.nih.gov/nuccore). 
The optimized primers (Table 1) were designed and 
validated by Roche® Probe Finder 2.5 (access: 
http://qpcr.probefinder.com/organism.jsp) using 
Primer3 version1.1.4. PCR amplification was carried 
out in the Rotor-Gene SYBR Green PCR kit from 
Qiagene and using the thermocycler Rotor Gene Q 
(Qiagen, Hilden, Germany). After an initial activation 
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step at 95°C for 5 min (hot start DNA polymerase 
activation), Reactions were run under the following 
conditions: 40 cycles of denaturation at 95°C for 5 s, 
combined annealing/extension at 60°C for 10 s at 
which the fluorescence was acquired. Amplification 
specificity was checked using the melting curve 
generated by heating the PCR product slowly at a 
rate of 1°C s−1 from 60°C to 95°C. Relative levels of 
gene expression were normalized to GAPDH mRNA 
levels. To avoid an impressing effect of inter-run 
variations on reference gene stability, the gene 
expression of all reference genes was quantified for 
each sample in triplets within the same qPCR plate. 
The PCR efficiency of the target genes, IL-4, IL-5, 
IL-13, MUC5a and endogenous control 
glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), was calculated from the slopes of the 
standard curves. 
Histopathology 
The number of eosinophils in bronchoalveolar 
lavage fluid was quantified in all animals. 
Histopathological sections were prepared and stained 
with Hematoxylin and Eosin (H&E) to detect 
eosinophilic infiltration and mucus-secreting goblet 
cells, respectively. 
Statistical analysis 
Gene expression changes were shown in the 
graphs on logarithmic scales. Columns in this graph 
represent average gene expression (in triplicate) ± 
standard deviation. The Kolmogorov-Smirnov test 
was used for normal distribution. One-way analysis 
of variance (ANOVA) and student's t-test were used 
to compare results from different groups, and 
differences in each group before and after treatment, 
respectively. The Mann-Whitney U test was applied 
to compare the differences between positive and 
negative groups. A p Value less than 0.05 were 
considered to be significant. 
Results 
Airway inflammation in mouse model of allergic 
asthma 
To confirm the allergic airway inflammation 
model, the positive and negative controls were 
compared in terms of differences between 
inflammatory cell infiltration around blood vessels 
and lung airways, the presence of eosinophils in the 
inflammatory cells and lavage fluid, increased 
numbers of goblet cells and mucus-secreting cells in 
the airways. The Mann-Whitney U test was used to 
compare positive and negative control groups. There 
were significant differences between the two groups in 
terms of eosinophilic lavage (P<0.05) (Fig. 1-A), 
eosinophilic lung inflammation around the airways 
(P<0.05) (Fig. 1-B) and mucus secretion (P<0.05) 
(Fig. 1-C). However, no significant difference was 
found in alveolar wall inflammation between negative 
and positive controls (P<0.8). This indicates an 
appropriate experimental model, because pulmonary 
alveolitis should not be detected in the asthma and 
allergic inflammation model. 
Real time-PCR for IL-4, IL-5, IL-13 and mucin 
genes 
Asthmatic mice treated with BS were able to 
suppress type-2cytokines expression in broncho-
alveolar fluid cells. In this study, mice sensitized with 
OVA displayed a significant increase in the relative 
expression of IL-4. Simply stated, IL-4 expression 
(Fig. 2) led to an increase about 4-8 fold, as compared 
to the control. However, OVA-stimulated mice treated 
with SB suppressed IL-4 expression. IL-5 (Fig. 2) and 
IL-13 (Fig. 2) displayed the same expression pattern as 
IL-4. However, the expression level was significantly 
diminished in mice receiving BS. OVA-stimulated BS 
treated mice showed down regulation of mucin gene 
expression. OVA-stimulated mice expressed high 
levels of mucin. BS- received mice had 11-12 fold 
decrease of mucin gene expression (Fig. 2). Therefore, 
it can be deduced that BS could reduce mucin 
expression in mice stimulated with OVA. 
Discussion 
Previous studies have shown that BS has 
immunomodulatory (16, 17), anti-inflammatory (18), 
anti-carcinogenic, mutagenic and anti-oxidant (19, 20) 
activities in a number of diseases, including allergic 
airway inflammation (21) and bronchial asthma (22). 
As compared to the controls, mice sensitized 
and challenged with OVA showed significant 
inflammatory changes, including increased Th2 
cytokines (such as IL4, IL5 and IL13), the presence of 
lung tissue eosinophils in Broncho-alveolar lavage 
(BAL) fluid, and a marked increase in the number of 
goblet cells. There is evidence that IL-4 is able to 
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induce the proliferation of Th2-type cells, 
differentiate B cells and, more importantly, decreases 
the production of Th1 cells (23, 24).  In the airways 
of OVA-sensitized and challenged mice, IL-5 plays a 
crucial role in the maturation and differentiation of 
eosinophils that leads to its numerical increase in the 
airways subsequent to activation (25). IL-13 is 
involved in AHR, promoting IgE isotype switching 
in B cells and importantly mucus secretion in the 
airway (26). Consistent with the above-mentioned 
studies, the modulation of local Th1/Th2 cytokine 
equilibrium could explain airway smooth muscle 
spasm improvement, decreased airway inflammation, 
decreased levels of OVA-specific IgE and IgG1, as 
well as increased levels of IgG2a (27, 28). 
In the present study, decreased Th2 cytokine 
expression in BS-treated mice compared with the 
sensitized group; the difference was clearly proved 
with statistical data. Therefore, it can be deduced that 
BS has a significant effect on IL-4, IL-5, IL-13, and 
MUC5a expression levels, consistent with previous 
studies (2, 8, 15). Results from real time-PCR 
showed that mice pretreated with BS exhibited 
significantly reduced expression levels of IL-4, IL-5, 
IL-13, and MUC5a in the airway. It suggests that BS 
has the anti-inflammatory effect on experimental 
asthma. Histological examination of lung tissue 
demonstrated that BS has the potential ability to 
inhibit allergen-induced lung eosinophilic 
inflammation and mucus production. In the present 
study, mice treated with BS could potentially suppress 
IL-4, IL-5, IL-13, and MUC5a gene expression in 
OVA sensitized and challenged mice.It demonstrates  
that BS acts mainly by suppressing type 2 cytokines 
and mucus secretion from the airways. 
These results demonstrated that BS has a 
protective role in allergic asthma in mice. In 
agreement with our findings, previous studies 
demonstrated that BS-treated mice not only decrease 
type 2 cytokines and MUC5a expression, but also 
exhibit a substantial decrease in eosinophil levels and 
mucus in asthmatic mice (22, 29). 
In addition, Balaha, M.F., et al. previously 
showed that OVA-sensitized and -challenged mice 
orally-treated with BS Oil are able to significantly 
decrease the number of total leukocytes, macrophages 









GAPDH Forward TGTTCCTACCCCCAATGTGT 20 138 
Reverse GGTCCTCAGTGTAGCCCAAG 20 
IL-4 Forward AGATCATCGGCATTTTGAACG 21 67 
Reverse TTTGGCACATCCATCTCCG 19 
IL-5 Forward ACATTGACCGCCAAAAAGAG 21 62 
Reverse ATCCAGGAACTGCCTCGTC 19 
IL-13 Forward GGTCCACACAGGGCAACT 18 43 
Reverse AATAAGATCAAGAAGAAATGTGCTCAA 27 
Muc5ac Forward CAGGACTCTCTGAAATCGTACCA 23 128 
Reverse AAGGCTCGTACCACAGGGA 19 
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and eosinophils, as well as IL-4, IL-5 and IL-13 
levels in BALF. Additionally, Boskabady et al. 
demonstrated that the hydroethanolic extract of BS 
can lead to a decrease in IL-4 production and an 
increase in IFN-γ production in the blood of OVA 
sensitized guinea pigs(14). Furthermore, Shahzad et 
al. have shown that BS Oil-treated rats exposed to 
OVA, clearly decrease the number of inflammatory 
cells  (eosinophils , macrophages and lymphocytes) 
in BALF, serum total IgE and IgG1 and significantly 
diminished the elevated levels of mRNA expression 
of IL-4, IL-5, IL-6 and TGF-b1(29, 30). Moreover, in 
this study we found a significantly increased in the 
BAL eosinophilic percentage in the sensitized, non-
treated group comparing with BS-treated group and 
non-asthmatic airways.  
BS-treated asthmatic mice significantly 
reduced percentage the assemblage of eosinophils 
compared with the sensitized, non-treated group. In 
previous studies, it has been demonstrated that 
eosinophils play a central pro-inflammatory role in 
the production of airway inflammation, bronchial 
hyper reactivity and allergic asthma (31, 32). And 
 
Fig. 1. Effects of BS on airway cellular infiltratio 24 h after the final antigen challenge. PBS: PBS-exposed 
group; OVA: n n-tre ted bronchial asthma group; BS: bronchial asthma group treated with 1 mg/kg/day BS. 
Chart results of eosinophils in the lavage fluid cell count (A), inflammation around lung bronchi (B), and the 





Fig. 2. Effect of BS on Th2 cytokine mRNA expression. Total RNA was extracted and used in Real 
Time-PCR to assess IL-4, IL-5, IL-13, and MUC5ac gene expression. Results from 14 Balb/c mice per 
each group are given. Data is given for PBS, OVA and BS group. Cytokines mRNA expression in mic 
BALF expressed as a percent ratio to GAPDH (internal control) mRNA determined by Real Time- PCR. 
Data is shown as mean ± SD for 14 BALB/c each group. A significant increase in the mRNA expression 
for all cytokines was noted in OVA-sensitized mice (OVA-group) as compared to PBS-treated controls. 
BS significantly reduced mRNA expression of IL-4 (P<0.05), IL-5 (P<0.05), IL-13 (P<0.05) and 
MUC5ac (P<0.05) in mice treated with BS. 
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one of the diagnostic features of these diseases, is an 
increase in the numbers of eosinophils (eosinophilia) 
in the peripheral blood and sputum (33). In this 
study, we surveyed mucus gene expression by real 
time-PCR localization using MUC5a gene in the BS-
treated group and non-asthmatic airways animals. In 
the previous studies, decreased expression of 
bronchial epithelial cells was recorded by Xiao et al 
who demonstrated that E-cadherin expression was 
significantly lower in the bronchial biopsies of 
asthmatic subjects compared with non-asthmatics 
ones (34). Additionally, Kulshreshtha et al showed 
that E-cadherin is a trans-membrane protein in 
epithelial cells that provides essential architectural 
structure and immunological function to the airway 
epithelium (35). Mucus hyper secretion in asthma 
results from airway inflammation and contributes to 
clinical symptoms, airway obstruction, and mortality 
(36). In human asthma and in animal models, mucus 
overproduction correlates with airway eosinophilia. 
Th2 cells stimulate airway eosinophilia and a marked 
increase in mucus production, Mucus could be 
induced by IL-13  (37). In the present study, we 
dissect further mechanisms of Th2-induced mucus 
production (38).  
We surveyed the anti-inflammatory and 
immunomodulatory effects of BS in a mouse model 
of allergic asthma by cytokines balancing with 
attention to airway function, antigen-induced 
inflammatory infiltrates in the airways, local Th2 
cytokine production, secretion of mucus in the 
airways, and histopathological changes of lung 
tissues. These data suggested that BS had 
immunomodulatory, anti-inflammatory, and mucus 
hypersecretion effects on OVA-induced asthma in 
mice due to inhibition of Th2 cytokine production, 
eosinophil infiltration, and excess mucus production 
into the airways. Therefore, BS can be recommended 
as a therapeutic agent for the treatment of allergic 
asthma. In addition, it is considerable to elucidate 
that BS could have such anti-inflammatory and 
immunomodulatory effects when was operated orally 
as the clinical operation route of the drug. 
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